BlackRock Fund Advisors - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$22,349,000
-42.3%
5,411,414
+13.1%
0.00%
-50.0%
Q3 2016$38,761,000
+9.7%
4,785,281
+5.6%
0.01%0.0%
Q2 2016$35,343,000
+0.1%
4,531,181
-0.9%
0.01%0.0%
Q1 2016$35,306,000
-26.8%
4,573,313
+2.3%
0.01%
-27.3%
Q4 2015$48,244,000
+47.8%
4,471,134
-5.3%
0.01%
+37.5%
Q3 2015$32,639,000
-15.0%
4,723,459
+9.0%
0.01%
-11.1%
Q2 2015$38,387,000
-14.2%
4,332,613
-4.5%
0.01%
-18.2%
Q1 2015$44,742,000
-5.2%
4,537,734
+17.8%
0.01%
-8.3%
Q4 2014$47,178,000
+35.6%
3,851,254
+10.5%
0.01%
+20.0%
Q3 2014$34,782,000
+29.4%
3,485,121
-1.9%
0.01%
+25.0%
Q2 2014$26,888,000
+125.8%
3,551,912
-1.9%
0.01%
+100.0%
Q1 2014$11,910,000
+3.3%
3,620,099
+4.2%
0.00%0.0%
Q4 2013$11,531,000
+7.7%
3,474,382
-2.0%
0.00%0.0%
Q3 2013$10,708,000
-57.5%
3,545,705
+15.2%
0.00%
-55.6%
Q2 2013$25,182,0003,078,4350.01%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders